Blue Jet Healthcare Limited
The Vizag capex is the sprint; the RFP pipeline is the finish line. The latest print firmed up, but the stock's price already assumes the whole race is won.
Overall read
5.1/10
Weak & rich
The three reads · this quarter
The Vizag capex is the sprint; the RFP pipeline is the finish line. The latest print firmed up, but the stock's price already assumes the whole race is won.
Overall read
5.1/10
Weak & rich
The three reads · this quarter
The Vizag capex is the sprint; the RFP pipeline is the finish line. The latest print firmed up, but the stock's price already assumes the whole race is won.
Overall read
5.1/10
Weak & rich
The three reads · this quarter
The standing reads · change less often
Moat
Moderate edge
Key variables
3 tracked
lead: RFP pipeline (active RFPs count)The RFP pipeline has more than doubled since Q2 FY25, indicating strong demand tailwinds from innovator de-risking and new therapy areas. The number of late-stage opportunities suggests near-term conversion potential, though management has not disclosed win ra
Walk the talk
Not enough tracked guidance to grade yet.
Vizag greenfield project (INR 1,000 Cr capex) is the key long-term growth driver, with Phase 1 capacity planned against customer commitments.
Latest · newest first
3w ago · Business Update
Earnings call transcript for Q1 FY2026 results.
3w ago · Business Update
Investor presentation for Q1 FY2026 results.
20 Jul 2026 · Business Update
Blue Jet Healthcare receives silver medal from EcoVadis for sustainability.
09 Jul 2026 · Fundraising
Investment & Finance Committee approves QIP.
09 Jul 2026 · Fundraising
Investment & Finance Committee approves QIP.
Where it sits